When a child or teen is carrying extra weight, their body can start to struggle with using insulin properly—a condition called insulin resistance. This can set the stage for future health problems. So, what's the best way to use exercise to help? A major review of past research, involving over 3,200 young people, tried to answer that by comparing different workout styles. It found that short bursts of very intense exercise, known as high-intensity interval training or HIIT, were most effective at lowering fasting insulin levels and a key resistance marker called HOMA-IR. For directly lowering fasting blood sugar, a combination of aerobic exercise (like running) and resistance training (like lifting weights) worked best. The analysis showed that aerobic exercise on its own improved all three markers, while resistance training alone didn't show significant effects—though it did provide a crucial boost when added to other exercises in a combined program. It's important to note this is a review of existing evidence, showing associations, not direct cause-and-effect from a single new trial. The researchers also noted some 'small-study effects' for certain outcomes, which means results from smaller studies might slightly overstate the benefits. Most importantly, while this points to promising strategies, the review itself concludes that future research needs to define the optimal intensity and duration of these exercises for young people.
Which exercise works best for insulin resistance in kids with extra weight?
Photo by Towfiqu barbhuiya / Unsplash
What this means for you:
For insulin resistance, HIIT shows promise for kids, but the perfect workout plan isn't defined yet. More on Obesity
Oral Sodium Butyrate Reduces Weight in Overweight Adults Without Diabetes Oral sodium butyrate helps overweight adults without diabetes lose weight
· May 1, 2026
Narrative review links microgravity exposure to altered fat distribution and inflammation in metabolic disease models. How Space Travel Is Unlocking New Ways to Fight Obesity and Diabetes
Frontiers · Apr 24, 2026
GZR18 showed weight loss in Chinese adults with overweight or obesity in a phase 1b/2a trial. New Drug Cuts Weight by Nearly 20% in Just 35 Weeks
· Apr 23, 2026
Tirzepatide MTD Demonstrates Cost-Effectiveness Versus Semaglutide MTD in Obesity Simulation Modeling Study Tirzepatide Saves Money and Health Over Semaglutide
· Apr 22, 2026